Zobrazeno 1 - 10
of 1 487
pro vyhledávání: '"chronic rhinosinusitis with nasal polyps"'
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 1027-1040 (2024)
Mona Al-Ahmad,1,2,* Asmaa Ali,2– 4,* Haitham A Dawood,5 Gerges M Beshreda6 1Department of Microbiology, College of Medicine, Kuwait University, Kuwait City, Kuwait; 2Department of Allergy, Al-Rashed Allergy Center, Ministry of Health, Kuwai
Externí odkaz:
https://doaj.org/article/6d546259b49341f9b65a335c66e0d6a4
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 901-910 (2024)
Yuan Yuan,1 Ze Wu,2 Xu Chen,3 Bin Xie2 1Department of Pathology, Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, P
Externí odkaz:
https://doaj.org/article/7313f3cca2be4e2ab65aa29655433ea0
Autor:
Spencer I. Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A. Gilbert, Jessica Y. Mancuso, Karen Page, Jean S. Beebe, Elena Peeva, Michael S. Vincent
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 20, Iss 1, Pp 1-8 (2024)
Abstract PF-06817024 is a humanized antibody against interleukin-33 that has the potential to inhibit type 2 inflammation. An exploratory analysis of the pharmacodynamics and clinical effects of single and repeat doses of PF-06817024 was assessed in
Externí odkaz:
https://doaj.org/article/342daf6733c54dea9222dbbb5a9d74c3
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 3791-3809 (2024)
Yujie Li,1 Yadong Yin,2 Juan Xiong,3 Zhipeng Zhang,4 Linglong Li,3 Baoshun Zhang,4 Feng Zhang,3 Dehong Mao3 1College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, People’s Republic of China; 2Xijing Hospital, Air Force M
Externí odkaz:
https://doaj.org/article/55484c9ce9e742e4afdadbe82c701594
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 5619-5631 (2024)
Siyuan Chen,1,2 Jia Liu,1,2 Zhili Feng,1,2 Liubo Zhou,1,2 Yuexiang Cai,1,2 Qiancheng Jing1,2 1Department of Otolaryngology Head and Neck Surgery, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha,
Externí odkaz:
https://doaj.org/article/76be5ffd9f57449ca2e6d34f230e3be5
Autor:
Amber U. Luong, MD, PhD, Joshua M. Levy, MD, MPH, MSc, Ludger Klimek, MD, PhD, Richard J. Harvey, MD, Jared Silver, MD, PhD, Steven G. Smith, PhD, Abby Fuller, MSc, Robert Chan, MD, Peter W. Hellings, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100327- (2024)
Background: In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps. Objective: Our aim was to investigate r
Externí odkaz:
https://doaj.org/article/fd28a8839e0744b1ad824720015c58c9
Autor:
Manon Blauwblomme, Philippe Gevaert, Sharon Van Nevel, Sebastian Riemann, Elke Vandewalle, Gabriele Holtappels, Natalie De Ruyck, Lara Derycke, Anne-Sophie Eeckels, Stijn Vanhee, Bart N. Lambrecht, Guy Brusselle, Thibaut Van Zele
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
ContextRecent insights into type 2 inflammation have led to the development of monoclonal antibody therapies for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Despite add-on therapy with a monoclonal antibody, some individuals
Externí odkaz:
https://doaj.org/article/5788d24459c043d2a013ed0b837983f4
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundChronic rhinosinusitis with nasal polyps (CRSwNP) belongs to a subtype of Chronic rhinosinusitis which is a heterogeneous inflammatory condition. It has been reported that mitophagy may provide a new therapeutic option for CRSwNP.MethodsThe
Externí odkaz:
https://doaj.org/article/af2f23b440bc4bdba196a46bea9991cb
Autor:
Sara Munari, Giulia Ciotti, Walter Cestaro, Lorenzo Corsi, Silvia Tonin, Andrea Ballarin, Ariel Floriani, Cristina Dartora, Annamaria Bosi, Matteo Tacconi, Francesco Gialdini, Michele Gottardi, Francesco Menzella
Publikováno v:
Drugs in Context, Vol 13, Pp 1-11 (2024)
Type 2 inflammation is a heterogeneous condition due to the complex activation of different immunological pathways. Rapid progress in research to evaluate the efficacy of biologics for chronic rhinosinusitis with nasal polyps and asthma has led to th
Externí odkaz:
https://doaj.org/article/1e42124b70ab414eb73dc6044feeb92c
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 2991-3002 (2024)
Chengetai R Mahomva,1,* Kristine A Smith,1,* Prince AB Minkah,2 Benjamin L Witt,3 Gretchen M Oakley,1 Richard R Orlandi,1 Jeremiah A Alt,1,2,4 Abigail Pulsipher1,2,4 1Department of Otolaryngology-Head and Neck Surgery, University of Utah Scho
Externí odkaz:
https://doaj.org/article/d11d80fc7f5f4550be2f2a6d780b6c20